Related Experiment Video
Updated: May 5, 2026
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
miR-210: fine-tuning the hypoxic response
1Department of Medicine, Indiana University, 980 W. Walnut Street Walther Hall, Room C225, Indianapolis, IN, 46202, USA, mivan@iupui.edu.
Abstract:
Hypoxia is a central component of the tumor microenvironment and represents a major source of therapeutic failure in cancer therapy. Recent work has provided a wealth of evidence that noncoding RNAs and, in particular, microRNAs, are significant members of the adaptive response to low oxygen in tumors. All published studies agree that miR-210 specifically is a robust target of hypoxia-inducible factors, and the induction of miR-210 is a consistent characteristic of the hypoxic response in normal and transformed cells. Overexpression of miR-210 is detected in most solid tumors and has been linked to adverse prognosis in patients with soft-tissue sarcoma, breast, head and neck, and pancreatic cancer. A wide variety of miR-210 targets have been identified, pointing to roles in the cell cycle, mitochondrial oxidative metabolism, angiogenesis, DNA damage response, and cell survival. Additional microRNAs seem to be modulated by low oxygen in a more tissue-specific fashion, adding another layer of complexity to the vast array of protein-coding genes regulated by hypoxia.
Insights
MicroRNAs, such as miR-210, are key players in how tumors adapt to low oxygen (hypoxia). This microRNA is overexpressed in many cancers and linked to poor patient prognosis.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Hypoxia is a critical factor in the tumor microenvironment, often leading to cancer therapy failure.
- Noncoding RNAs, especially microRNAs, are integral to cellular adaptation to hypoxic conditions.
- miR-210 is consistently induced by hypoxia and overexpressed in various solid tumors.
Purpose of the Study:
- To investigate the role of microRNAs, particularly miR-210, in the hypoxic tumor microenvironment.
- To understand the implications of miR-210 overexpression in cancer prognosis and therapeutic resistance.
Main Methods:
- Analysis of published studies on microRNA expression and function under hypoxic conditions.
- Identification of miR-210 targets and their associated cellular pathways.
Main Results:
- miR-210 is a robust target of hypoxia-inducible factors and a consistent marker of hypoxic response.
- Overexpression of miR-210 correlates with adverse prognosis in several cancer types (e.g., sarcoma, breast, head and neck, pancreatic).
- Identified miR-210 targets are involved in cell cycle, metabolism, angiogenesis, DNA damage response, and survival.
Conclusions:
- miR-210 is a significant mediator of the cellular response to tumor hypoxia.
- miR-210 plays a multifaceted role in cancer progression and may represent a therapeutic target.
Related Concept Videos
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:23Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...